We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$9.99B
AUM Growth
+$475M
Cap. Flow
-$113M
Cap. Flow %
-1.13%
Top 10 Hldgs %
8.79%
Holding
968
New
62
Increased
353
Reduced
363
Closed
57

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$25M
2
FCNCA icon
First Citizens BancShares
FCNCA
+$23.1M
3
NEWT icon
NewtekOne
NEWT
+$21.4M
4
AGO icon
Assured Guaranty
AGO
+$18.9M
5
TECH icon
Bio-Techne
TECH
+$18.7M

Sector Composition

Rank Sector Weight
1 Industrials 27.54%
2 Technology 18.26%
3 Consumer Discretionary 12.96%
4 Financials 12.6%
5 Materials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
276
Lantheus
LNTH
$6.58B
$11M 0.11%
132,800
+12,000
+10% +$774K
LFUS icon
277
Littelfuse
LFUS
$11.2B
$11M 0.11%
40,871
ARCB icon
278
ArcBest
ARCB
$3.17B
$11M 0.11%
118,526
+275
+0.2% +$24.7K
ETD icon
279
Ethan Allen Interiors
ETD
$583M
$10.9M 0.11%
397,773
-8,582
-2% -$244K
VREX icon
280
Varex Imaging
VREX
$467M
$10.9M 0.11%
599,939
+76,341
+15% +$1.45M
BHE icon
281
Benchmark Electronics
BHE
$2.85B
$10.9M 0.11%
458,700
+35,800
+8% +$906K
KTB icon
282
Kontoor Brands
KTB
$4.63B
$10.9M 0.11%
224,405
-23,771
-10% -$1.13M
CAMT icon
283
Camtek
CAMT
$6.4B
$10.9M 0.11%
382,913
+17,900
+5% +$477K
HRMY icon
284
Harmony Biosciences
HRMY
$2.08B
$10.9M 0.11%
332,329
+102,059
+44% +$4.65M
DSKE
285
DELISTED
Daseke, Inc. Common Stock
DSKE
$10.8M 0.11%
1,398,951
+71,100
+5% +$522K
FLEX icon
286
Flex
FLEX
$41B
$10.8M 0.11%
623,267
-32,378
-5% -$560K
ADTN icon
287
Adtran
ADTN
$682M
$10.7M 0.11%
674,629
+6,022
+0.9% +$104K
SEM
288
DELISTED
Select Medical
SEM
$10.6M 0.11%
761,498
-6,125
-0.8% -$90.2K
PPLI
289
People Inc
PPLI
$3.08B
$10.6M 0.11%
250,136
+82,404
+49% +$3.53M
FHB icon
290
First Hawaiian
FHB
$3.4B
$10.6M 0.11%
512,707
+12,286
+2% +$310K
ASC icon
291
Ardmore Shipping
ASC
$703M
$10.6M 0.11%
709,999
-174,600
-20% -$2.74M
SAMG icon
292
Silvercrest Asset Management
SAMG
$76.1M
$10.5M 0.11%
579,061
-7,328
-1% -$132K
CIVI
293
DELISTED
Civitas Resources
CIVI
$10.5M 0.11%
154,009
+62,479
+68% +$4.05M
SNDR icon
294
Schneider National
SNDR
$5.98B
$10.5M 0.11%
392,525
-9,200
-2% -$248K
TMHC
295
DELISTED
Taylor Morrison
TMHC
$10.5M 0.1%
273,695
-11,111
-4% -$390K
TRN icon
296
Trinity Industries
TRN
$2.73B
$10.5M 0.1%
429,542
-33,400
-7% -$888K
RMR icon
297
The RMR Group
RMR
$333M
$10.5M 0.1%
398,738
+31,000
+8% +$869K
TTGT icon
298
TechTarget
TTGT
$325M
$10.4M 0.1%
288,523
-28,657
-9% -$1.2M
KN icon
299
Knowles
KN
$3.08B
$10.4M 0.1%
609,449
-83,100
-12% -$1.45M
RMBS icon
300
Rambus
RMBS
$9.72B
$10.3M 0.1%
201,652
-20,638
-9% -$886K

Similar funds

Royce & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Royce & Associates held 968 positions worth $9.99B, up 5% from $9.52B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates's Q1 2023 filing shows 62 new, 353 increased, 363 reduced and 57 closed positions. Its largest new stake was Innovex International: 284,752 shares worth $8.17M. The largest sale was Interparfums, an estimated $35.1M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Royce & Associates's largest Q1 2023 buy was Innovex International: 284,752 shares worth $8.17M.
  • Royce & Associates added most to RB Global in Q1 2023, an estimated $25M increase.
  • Royce & Associates's biggest Q1 2023 reduction was Interparfums, cutting an estimated $35.1M.
  • Royce & Associates fully exited nVent Electric in Q1 2023, selling an estimated $7.89M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $9.99B portfolio in Q1 2023.
  • Royce & Associates opened 62 new positions and closed 57 in Q1 2023.
  • Royce & Associates's portfolio value rose 5% quarter-over-quarter to $9.99B.

Based on Royce & Associates's 13F filing for Q1 2023, filed 4 May 2023.